索拉非尼 Sorafenib
（重定向自Nexavar）
索拉非尼（Sorafenib），商品名蕾莎瓦（Nexavar® ） ，是美国拜耳股份有限公司的专利药，经美国食品药物管理局核可用于治疗肾细胞肾癌（Renal cell carcinoma）及肝癌（Hepatocellular carcinoma）。2012年8月1日，**健保局通过健保给付蕾莎瓦，支付价每颗1092元，平均每月药费13万元。
Nexavar
中文百科
英语百科
Sorafenib 索拉非尼
（重定向自Nexavar）
![](/Images/godic/202501/29/Sorafenib2DACS.svg2318.png")
![](/Images/godic/202501/29/Sorafenib3Dan2318.gif")
Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar), is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.
- taped bush
- tapedeck
- tape deck
- Tape Delay
- tape delays
- tape delay system
- tape delivery
- taped ends
- tape depth gauge
- tape device
- tape device data block
- taped forming and assembling machine
- taped insulation
- taped interview
- tape disk operating system
- Tape dispenser
- tape dispensing
- tape dispensing head
- tape distortion
- tape divider
- taped lectures
- taped measurement
- Taped out
- tape drive
- tape drive controller